Glenmark Pharmaceuticals Ltd.

Cases where party is a Patent Asserter

Only "example" cases are shown here, for full list contact Shawn Miller

Cases where party is an Alleged Infringer

Displaying 1 - 23 of 23
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
1 Biogen International GmbH et al v. Glenmark Pharmaceuticals Limited et al 1:17-cv-00852 D.Del.
  • 8 Product company
Biogen International GmbH
2 Biogen International GmbH et al v. Glenmark Pharmaceuticals Limited et al 1:17-cv-00852 D.Del.
  • 8 Product company
Biogen MA Inc.
3 Sanofi et al v. Glenmark Pharmaceuticals Inc. USA et al 1:15-cv-01206 D.Del.
  • 8 Product company
Sanofi-Aventis U.S. LLC
4 Sanofi et al v. Glenmark Pharmaceuticals Inc. USA et al 1:15-cv-01206 D.Del.
  • 8 Product company
Sanofi S.A.
5 ASTRAZENECA PHARMACEUTICALS LP et al v. GLENMARK PHARMACEUTICALS INC., USA et al 1:15-cv-00615 D.N.J.
  • 8 Product company
Astrazeneca, UK Limited
6 ASTRAZENECA PHARMACEUTICALS LP et al v. GLENMARK PHARMACEUTICALS INC., USA et al 1:15-cv-00615 D.N.J.
  • 8 Product company
Astrazeneca Pharmaceuticals LP
7 ASTRAZENECA PHARMACEUTICALS LP et al v. GLENMARK PHARMACEUTICALS INC., USA et al 1:15-cv-00615 D.N.J.
  • 8 Product company
Astrazeneca AB
8 Sanofi et al v. Watson Laboratories Inc. et al 1:14-cv-00264 D.Del.
  • 8 Product company
Sanofi-Aventis U.S. LLC
9 Sanofi et al v. Watson Laboratories Inc. et al 1:14-cv-00264 D.Del.
  • 8 Product company
Sanofi S.A.
10 ELI LILLY AND COMPANY v. GLENMARK GENERICS INC., USA 1:14-cv-00104 S.D.Ind.
  • 8 Product company
Eli Lilly & Co
11 Glenmark Pharmaceuticals Ltd. et al v. GlaxoSmithKline PLC et al 1:13-cv-00135 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
12 Glenmark Pharmaceuticals Ltd. et al v. GlaxoSmithKline PLC et al 1:13-cv-00135 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
Smithkline Beecham
13 Glenmark Pharmaceuticals Ltd. et al v. GlaxoSmithKline PLC et al 1:13-cv-00135 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
Glaxosmithkline PLC
14 Glenmark Pharmaceuticals Ltd. et al v. GlaxoSmithKline PLC et al 1:13-cv-00135 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
Beecham Group, P.L.C.
15 Glenmark Pharmaceuticals Ltd. et al v. GlaxoSmithKline PLC et al 1:13-cv-00135 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
Stiefel Laboratories, Inc.
16 Glenmark Pharmaceuticals Ltd. et al v. GlaxoSmithKline PLC et al 1:13-cv-00135 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
GlaxoSmithKline LLC
17 Triax Pharmaceuticals LLC et al v. Glenmark Generics Inc USA et al 1:10-cv-00946 D.Del.
  • 8 Product company
Astellas Pharma International B.V.
18 Triax Pharmaceuticals LLC et al v. Glenmark Generics Inc USA et al 1:10-cv-00946 D.Del.
  • 8 Product company
Astellas Pharma Europe B.V.
19 Triax Pharmaceuticals LLC et al v. Glenmark Generics Inc USA et al 1:10-cv-00946 D.Del.
  • 8 Product company
Triax Pharmaceuticals, LLC
20 SANOFI-AVENTIS DEUTSCHLAND GMBH et al v. GLENMARK PHARMACEUTICALS INC., USA et al 2:08-cv-01658 D.N.J.
  • 8 Product company
Aventis Pharma S.A.
21 SANOFI-AVENTIS DEUTSCHLAND GMBH et al v. GLENMARK PHARMACEUTICALS INC., USA et al 2:08-cv-01658 D.N.J.
  • 8 Product company
Abbott GmbH & Co., KG
22 SANOFI-AVENTIS DEUTSCHLAND GMBH et al v. GLENMARK PHARMACEUTICALS INC., USA et al 2:08-cv-01658 D.N.J.
  • 8 Product company
Sanofi-Aventis Deutschland GmbH
23 SANOFI-AVENTIS DEUTSCHLAND GMBH et al v. GLENMARK PHARMACEUTICALS INC., USA et al 2:08-cv-01658 D.N.J.
  • 8 Product company
Abbott Laboratories